Wave Life Sciences (WVE) Equity Ratio (2016 - 2025)
Wave Life Sciences (WVE) has disclosed Equity Ratio for 11 consecutive years, with 0.81 as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Equity Ratio rose 36.47% year-over-year to 0.81, compared with a TTM value of 0.81 through Dec 2025, up 36.47%, and an annual FY2025 reading of 0.81, up 36.47% over the prior year.
- Equity Ratio was 0.81 for Q4 2025 at Wave Life Sciences, up from 0.52 in the prior quarter.
- Across five years, Equity Ratio topped out at 0.81 in Q4 2025 and bottomed at 0.31 in Q4 2022.
- Average Equity Ratio over 5 years is 0.18, with a median of 0.14 recorded in 2022.
- The sharpest move saw Equity Ratio tumbled 40913.58% in 2023, then surged 3414.34% in 2025.
- Year by year, Equity Ratio stood at 0.16 in 2021, then plummeted by 296.21% to 0.31 in 2022, then soared by 146.79% to 0.14 in 2023, then soared by 312.71% to 0.59 in 2024, then skyrocketed by 36.47% to 0.81 in 2025.
- Business Quant data shows Equity Ratio for WVE at 0.81 in Q4 2025, 0.52 in Q3 2025, and 0.55 in Q2 2025.